GRL-0519, a Novel Oxatricyclic Ligand-Containing Nonpeptidic HIV-1 Protease Inhibitor (PI), Potently Suppresses Replication of a Wide Spectrum of Multi-PI-Resistant HIV-1 Variants In Vitro

MLA

Amano, Masayuki, et al. “GRL-0519, a Novel Oxatricyclic Ligand-Containing Nonpeptidic HIV-1 Protease Inhibitor (PI), Potently Suppresses Replication of a Wide Spectrum of Multi-PI-Resistant HIV-1 Variants In Vitro.” Antimicrobial Agents and Chemotherapy, vol. 57, no. 5, Mar. 2013, pp. 2036–46. EBSCOhost, https://doi.org/10.1128/AAC.02189-12.

APA

Amano, M., Tojo, Y., Salcedo-Gómez, P. M., Campbell, J. R., Das, D., Aoki, M., Xu, C.-X., Rao, K. V., Ghosh, A. K., & Mitsuya, H. (2013). GRL-0519, a Novel Oxatricyclic Ligand-Containing Nonpeptidic HIV-1 Protease Inhibitor (PI), Potently Suppresses Replication of a Wide Spectrum of Multi-PI-Resistant HIV-1 Variants In Vitro. Antimicrobial Agents and Chemotherapy, 57(5), 2036–2046. https://doi.org/10.1128/AAC.02189-12

Chicago

Amano, Masayuki, Yasushi Tojo, Pedro Miguel Salcedo-Gómez, Joseph Richard Campbell, Debananda Das, Manabu Aoki, Chun-Xiao Xu, Kalapala Venkateswara Rao, Arun K. Ghosh, and Hiroaki Mitsuya. 2013. “GRL-0519, a Novel Oxatricyclic Ligand-Containing Nonpeptidic HIV-1 Protease Inhibitor (PI), Potently Suppresses Replication of a Wide Spectrum of Multi-PI-Resistant HIV-1 Variants In Vitro.” Antimicrobial Agents and Chemotherapy 57 (5): 2036–46. doi:10.1128/AAC.02189-12.